BioAsia forges prominent partnerships for its 10th edition
Spain joins in as the Country Partner and Victoria (Australia) is the international state partner
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
M&A activity in pharma market continue to focus on increasing product offerings
Indian pharmaceutical sector witnesses no deals during December 2012
Predictions fromPharma Pundits
As 2013 rolls in, Express Pharma presents insights from industry experts on the sector's performance in 2013
IPM grows 4.1 per cent, valued at Rs 5939 crore in November 12
Abbott, Sun Pharma cross Rs 300 crore in monthly sales
State drug regulators equally responsible for clinical trial activities: DCGI
In a watchdog role, state regulators now mandated to accompany CDSCO officers on clinical trial site inspections
Claris in JV with Otsuka, Mitsui for injectables
Deal gives Otsuka entry into IV solution/ clinical nutrition business in India, emerging markets
iPHEX 2013 to showcase Indian pharma exports; R&D capabilities
Over 400 international buyers and regulators expected at iPHEX 2013
BioAsia and BioRx to host workshop on private equity
To be held on January 28 on the sidelines of BioAsia-2013
Nominations invited for Healthcare & Pharma HR of The Year, HarNeedi TREE Awards 2012
Instituted to honour HR professionals in the healthcare and pharma fraternity, HR of the Year, HarNeedi TREE Awards 2012 are the…
Pharma-2012 conference focuses on regulatory affairs
The two-day conference had four parallel scientific sessions with about 150 lectures and 300 poster presentations
‘Envisioning affordable healthcare for all’
The Omidyar Network and the Delhi branch of The Indus Entrepreneurs (TiE) organised a conference to bring eminent panelists from…
CII organises Life Science Conclave in Delhi
Sees participation from industry stalwarts, academia and other stakeholders in the lifesciences industry
5th edition of Bangalore Nano sees record participation
Discussions, lectures and presentations were held on Nanoscience and Nanotechnology
Mylan to supply ARVs to South African National Department of Health
Company secured 19.1 per cent of R5.9 billion tender value for 2013
GSK, J&J, Sanofi top this year’s Access to Medicine Index
Report finds Big Pharma doing more for access to medicine in developing countries than two years ago